Product Information
AMPHETAMINE ER 15.7 MG ODT is a generic product labeled by Neos Therapeutics Brands, LLC, priced at $16.0418 per EA under NDC 62542002530. Its NADAC has been published 31 times since Jan 21, 2026.
FDA first approved this application on Jan 27, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
15.7 mg/1
Manufacturer
Neos Therapeutics Brands, LLCNDC
62542002530
Classification
Generic
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
AMPHETAMINEApproval Type
Authorized Generic (NDA)
FDA Application
NDA204326FDA Approved
1/27/2016
TE Code
AB
On Market Since
9/1/2025
Pharmacological Classes
Price Statistics
The NADAC for AMPHETAMINE ER 15.7 MG ODT has been published 31 times since Jan 21, 2026, and over the history we have for it it has declined 2.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $16.0418 per EA |
|---|---|
| All-time high | $16.5381 (Apr 15, 2026) |
| All-time low | $15.9385 (Jul 22, 2026) |
| 52-week high | $16.5381 |
| 52-week low | $15.9385 |
| Median price | $16.3645 |
| Average price | $16.2727 |
| Largest weekly change | -1.3% (May 20, 2026) |
| Weeks tracked | 31 |
| Tracking since | Jan 21, 2026 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Amphetamine Extended-Release market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of AMPHETAMINE ER 15.7 MG ODT?
The current National Average Drug Acquisition Cost (NADAC) for AMPHETAMINE ER 15.7 MG ODT, manufactured by Neos Therapeutics Brands, LLC, is $16.0418 per EA (NDC 62542002530), effective Aug 19, 2026.
How has the price of AMPHETAMINE ER 15.7 MG ODT changed over time?
Over the history we have for it, the NADAC for AMPHETAMINE ER 15.7 MG ODT has declined 2.9%. It has been tracked across 31 weekly CMS publications since Jan 21, 2026.
What are the highest and lowest recorded NADAC prices for AMPHETAMINE ER 15.7 MG ODT?
Since Jan 21, 2026, the NADAC for AMPHETAMINE ER 15.7 MG ODT has ranged from a low of $15.9385 (Jul 22, 2026) to a high of $16.5381 (Apr 15, 2026), with a median of $16.3645 per EA.
Are there cheaper alternatives to AMPHETAMINE ER 15.7 MG ODT?
No other NADAC-published product currently shares the active ingredient and strength of AMPHETAMINE ER 15.7 MG ODT in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures AMPHETAMINE ER 15.7 MG ODT?
AMPHETAMINE ER 15.7 MG ODT (NDC 62542002530) is labeled by Neos Therapeutics Brands, LLC, and CMS classifies it as a generic product.